Relay Therapeutics reported revenue of $0.35M and net income of -$85.09M for the quarter ended Jun 2026, down 48.3% year over year. This income statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 92.80M | 108.21M | 108.43M | 108.81M | 120.81M | 121.11M | 121.48M | 121.94M | 123.16M | 127.46M | 132.30M | 133.32M | 166.89M | 167.76M | 170.48M | 171.69M | 172.63M | 173.87M | 189.21M | 218.53M | |||||||||
| Revenue & cost | |||||||||||||||||||||||||||||
| Revenue | 0.67M | 0.57M | 0.42M | 0.36M | 0.34M | 0.25M | 0.23M | 0.12M | 25.20M | -0.00M | 10.01M | 7.68M | 0.68M | 7.00M | 3.00M | 0.35M | |||||||||||||
| Operating items | |||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 44.97M | 51.91M | 51.67M | 60.51M | 66.90M | 67.28M | 82.83M | 88.20M | 81.49M | 77.50M | 82.40M | 91.99M | 76.62M | 68.08M | 73.81M | 63.90M | 68.26M | 55.41M | 70.56M | 76.48M | |||||||||
| Selling, General & AdministrativeSG&A | 14.68M | 15.55M | 16.07M | 17.46M | 16.07M | 16.37M | 19.58M | 20.12M | 18.48M | 16.77M | 19.80M | 20.14M | 19.75M | 16.90M | 18.74M | 13.63M | 12.13M | 12.21M | 11.03M | 14.69M | |||||||||
| Other Operating ExpensesOther Opex | 2.00M | 0.84M | -4.59M | 0.20M | 3.26M | -10.54M | -1.00M | -2.15M | -1.20M | -2.07M | -1.83M | -11.37M | |||||||||||||||||
| Operating ExpensesOpex | 61.66M | 68.29M | 63.14M | 78.18M | 86.24M | 73.10M | 101.40M | 106.17M | 98.78M | 92.19M | 100.37M | 100.76M | 96.37M | 84.98M | 92.55M | 77.52M | 80.39M | 67.63M | 81.59M | 91.17M | |||||||||
| Operating IncomeOp. Inc | -60.99M | -67.72M | -62.72M | -77.81M | -85.89M | -72.85M | -101.18M | -106.05M | -73.58M | -92.20M | -90.36M | -100.76M | -96.37M | -84.98M | -84.87M | -76.85M | -80.39M | -60.63M | -78.59M | -90.82M | |||||||||
| EBIT | -60.99M | -67.72M | -62.72M | -77.81M | -85.89M | -72.85M | -101.18M | -106.05M | -73.58M | -92.20M | -90.36M | -100.76M | -96.37M | -84.98M | -84.87M | -76.85M | -80.39M | -60.63M | -78.59M | -90.82M | |||||||||
| Non-operating items | |||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.02M | 0.00M | 0.01M | 0.05M | |||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.16M | -1.72M | -8.13M | -2.69M | 1.71M | 2.97M | 6.94M | 7.56M | 7.84M | 8.70M | 8.95M | 8.55M | 8.27M | 8.97M | 7.81M | 7.11M | 6.41M | 5.71M | 5.35M | 7.12M | |||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.16M | 0.27M | 0.68M | 1.02M | 1.72M | 5.35M | 6.94M | 7.54M | 7.84M | 8.70M | 8.98M | 8.54M | 8.26M | 8.97M | 7.80M | 6.47M | 6.24M | 5.74M | 5.30M | 7.12M | |||||||||
| Non Operating IncomeNon Op. Inc. | -0.02M | 0.02M | 0.01M | -0.02M | -0.00M | -0.01M | -0.00M | 0.00M | 0.03M | -0.00M | -0.01M | 0.00M | -0.01M | -0.63M | -0.17M | 0.03M | 0.00M | ||||||||||||
| Net income details | |||||||||||||||||||||||||||||
| EBT | -60.83M | -69.44M | -70.87M | -80.50M | -84.18M | -69.88M | -94.24M | -98.49M | -65.73M | -83.50M | -81.41M | -92.21M | -88.09M | -76.00M | -77.06M | -69.74M | -73.98M | -54.92M | -73.29M | -83.71M | |||||||||
| Profit After TaxPAT | -60.83M | -68.55M | -62.05M | -76.79M | -85.66M | -64.53M | -94.24M | -98.50M | -65.73M | -83.50M | -81.39M | -92.21M | -88.11M | -76.80M | -77.06M | -70.58M | -74.15M | -54.89M | -73.29M | -85.09M | |||||||||
| Income from Continuing OperationsIncome (Continuing) | -60.83M | -69.44M | -70.87M | -80.50M | -84.18M | -69.88M | -94.24M | -98.49M | -65.73M | -83.50M | -81.41M | -92.21M | -88.09M | -76.00M | -77.06M | -69.74M | -73.98M | -54.92M | -73.29M | -83.71M | |||||||||
| Consolidated Net IncomeConsol Net Inc. | -60.83M | -69.44M | -70.87M | -80.50M | -84.18M | -69.88M | -94.24M | -98.49M | -65.73M | -83.50M | -81.41M | -92.21M | -88.09M | -76.00M | -77.06M | -69.74M | -73.98M | -54.92M | -73.29M | -83.71M | |||||||||
| Income towards Parent CompanyParent Net Inc | -60.83M | -69.44M | -70.87M | -80.50M | -84.18M | -69.88M | -94.24M | -98.49M | -65.73M | -83.50M | -81.41M | -92.21M | -88.09M | -76.00M | -77.06M | -69.74M | -73.98M | -54.92M | -73.29M | -83.71M | |||||||||
| Preferred Dividend PaymentsPref Dividends | |||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -60.83M | -67.46M | -70.87M | -80.50M | -84.18M | -69.88M | -94.24M | -98.49M | -65.73M | -83.50M | -81.41M | -92.21M | -88.09M | -76.00M | -77.06M | -69.74M | -73.98M | -54.92M | -73.29M | -83.71M | |||||||||
| Additional items | |||||||||||||||||||||||||||||
| EPS (Basic) | -0.66 | -0.71 | -0.65 | -0.74 | -0.76 | -0.62 | -0.78 | -0.81 | -0.54 | -0.68 | -0.62 | -0.69 | -0.63 | -0.53 | -0.46 | -0.41 | -0.43 | -0.32 | -0.41 | -0.41 | |||||||||
| EPS (Diluted) | -0.66 | -0.71 | -0.65 | -0.74 | -0.76 | -0.62 | -0.78 | -0.81 | -0.54 | -0.68 | -0.62 | -0.69 | -0.63 | -0.53 | -0.46 | -0.41 | -0.43 | -0.32 | -0.41 | -0.41 | |||||||||
| Shares Outstanding | 92.69M | 95.14M | 108.29M | 108.64M | 110.91M | 112.23M | 121.32M | 121.68M | 122.23M | 122.58M | 130.84M | 132.82M | 140.23M | 142.87M | 169.23M | 171.26M | 172.39M | 171.59M | 179.85M | 202.85M | |||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 92.69M | 95.14M | 108.29M | 108.64M | 110.91M | 112.23M | 121.32M | 121.68M | 122.23M | 122.58M | 130.84M | 132.82M | 140.23M | 142.87M | 169.23M | 171.26M | 172.39M | 171.59M | 179.85M | 202.85M | |||||||||
| EBITDA | -60.99M | -67.72M | -62.72M | -77.81M | -85.89M | -72.85M | -101.18M | -106.05M | -73.58M | -92.20M | -90.36M | -100.76M | -96.37M | -84.98M | -84.87M | -76.85M | -80.39M | -60.63M | -78.59M | -90.82M | |||||||||
| Interest ExpensesInt Expense | 0.02M | 0.00M | 0.01M | 0.05M |